These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 282705)

  • 1. Antibody and complement-mediated cytotoxicity of nucleated cells. Inhibition by the sera of patients with acute lymphoblastic leukemia.
    Bock GH; Stitzel AE; Rittenhouse KW; Spitzer RE
    Transplantation; 1978 Dec; 26(6):415-9. PubMed ID: 282705
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased proportion of complement-receptor lymphocytes in the peripheral blood of patients with chronic lymphocytic leukemia.
    Pincus S; Bianco C; Nussenzweig V
    Blood; 1972 Sep; 40(3):303-10. PubMed ID: 5066536
    [No Abstract]   [Full Text] [Related]  

  • 3. Some immunological properties of lymphoid cells from patients with acute lymphatic leukaemia (ALL).
    Melief CJ; Schweitzer M; Zeylemaker WP; Verhagen EH; Eijsvoogel VP
    Clin Exp Immunol; 1973 Sep; 15(1):131-43. PubMed ID: 4520119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
    Borella L; Sen L; Casper JT
    J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute lymphoblastic leukemia and complement receptors.
    Richie E; Culbert S; Sullivan MP; Van Eys J
    Blood; 1978 Aug; 52(2):467. PubMed ID: 276388
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-dependent and spontaneous cell-mediated cytotoxicity in children with acute lymphoblastic leukemia.
    Láng I; Zoltán E; Révész T; Gergely P; Schuler D; Petranyi G
    Allergol Immunopathol (Madr); 1982; 10(5):341-5. PubMed ID: 6962671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common acute lymphoblastic leukemia antigen-positive cells in normal bone marrow.
    Hogeman PH; Veerman AJ; Huismans DR; Van Zantwijk IH
    Blood; 1985 Jul; 66(1):246-7. PubMed ID: 3159444
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro treatment with monoclonal antibody prior to autologous bone marrow transplantation in acute lymphoblastic leukemia.
    Ritz J; Sallan SE; Bast RC; Lipton JM; Nathan DG; Schlossman SF
    Haematol Blood Transfus; 1983; 28():117-23. PubMed ID: 6345287
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell surface markers and kinetic features in acute lymphoblastic leukaemia.
    Caligaris Cappio F; Novarino A; Matera L; Gavosto F
    Haematologica; 1981 Aug; 66(4):419-25. PubMed ID: 6797877
    [No Abstract]   [Full Text] [Related]  

  • 10. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
    Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
    Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin inhibition of antibody-dependent complement-mediated lysis.
    Wesolowski J; Ault K; Houghton R; Parkman R
    Exp Hematol; 1984 Oct; 12(9):700-5. PubMed ID: 6237929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement.
    Bast RC; Ritz J; Lipton JM; Feeney M; Sallan SE; Nathan DG; Schlossman SF
    Cancer Res; 1983 Mar; 43(3):1389-94. PubMed ID: 6337707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lysis of leukemia cells with a monoclonal antibody-cocktail (e.g. VIP-pool) and human complement].
    Reiners B; Thränhardt H; Häfer R; Zintl F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):84-96. PubMed ID: 2439421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cytotoxicity of murine monoclonal antibody LAM2 against human small-cell carcinoma in the presence of human complement: possible use for in vitro elimination of tumor cells from bone marrow.
    Stahel RA; Mabry M; Sabbath K; Speak JA; Bernal SD
    Int J Cancer; 1985 May; 35(5):587-92. PubMed ID: 2987136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface antigens on leukaemic myeloid cells. I. Distribution and movement of antigens reacting to antilymphocytic globulins.
    Bacigalupo A; Santini G; Piaggio G; Giordano D; Marmont AM
    Haematologica; 1977 Apr; 62(2):136-43. PubMed ID: 406171
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cell reactions of immunological significance studied in bone marrow and lymph node cultures].
    Berceanu S; Gociu M; Răileanu-Moţoiu I
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):453-64. PubMed ID: 5275846
    [No Abstract]   [Full Text] [Related]  

  • 17. Cooperation of normal and malignant lymphoid cells in the immune response against sheep erythrocytes.
    Boranić M; Hrsak I; Marotti T; Mazuran R; Silobrcić V
    Biomedicine; 1974 Jan; 21(1):9-12. PubMed ID: 4858487
    [No Abstract]   [Full Text] [Related]  

  • 18. Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation.
    Keating A; Whalen CK; Singer JW
    Br J Haematol; 1983 Dec; 55(4):623-8. PubMed ID: 6200132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane immunofluorescence in acute lymphoblastic leukemia.
    Stevenson PA; Mott MG
    N Engl J Med; 1973 May; 288(21):1127-8. PubMed ID: 4572652
    [No Abstract]   [Full Text] [Related]  

  • 20. An attempt to characterize lymphocytes of acute lymphoid leukaemia as T or B cells.
    Governa M; Massimo L; Rosanda C; Franchini MI; Tonda GP
    Biomedicine; 1973 Sep; 19(9):384-7. PubMed ID: 4600231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.